Search research articles
Contact Us
Filters
Showing results (371-380 of 404) with videos related to
Page
of 41
Sort By:
Journal of Hepatology
|
April 17, 2017
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Paul Y Kwo, Fred Poordad, Armen Asatryan, et al.
Nature Communications
|
April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection
Chansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Jason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
Journal of Hepatology
|
September 1, 2015
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Gregory J Dore, Brian Conway, Yan Luo, et al.
Annals of Internal Medicine
|
August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study
Jason Grebely, Gregory J Dore, Frederick L Altice, et al.
The International Journal on Drug Policy
|
May 25, 2024
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Timothy R Broady, Heather Valerio, Maryam Alavi, et al.
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JAMA
|
May 6, 2015
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis
Andrew J Muir, Fred Poordad, Jacob Lalezari, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection
Chaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Annals of Internal Medicine
|
August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Gregory J Dore, Frederick Altice, Alain H Litwin, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 404) with videos related to
Sort By:
Page
of 41
Journal of Hepatology
|
April 17, 2017
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Paul Y Kwo, Fred Poordad, Armen Asatryan, et al.
Nature Communications
|
April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection
Chansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Jason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
Journal of Hepatology
|
September 1, 2015
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials
Gregory J Dore, Brian Conway, Yan Luo, et al.
Annals of Internal Medicine
|
August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study
Jason Grebely, Gregory J Dore, Frederick L Altice, et al.
The International Journal on Drug Policy
|
May 25, 2024
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Timothy R Broady, Heather Valerio, Maryam Alavi, et al.
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JAMA
|
May 6, 2015
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis
Andrew J Muir, Fred Poordad, Jacob Lalezari, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection
Chaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Annals of Internal Medicine
|
August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial
Gregory J Dore, Frederick Altice, Alain H Litwin, et al.
Page
of 41